Viewing Study NCT01868932


Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2026-01-05 @ 5:56 PM
Study NCT ID: NCT01868932
Status: WITHDRAWN
Last Update Posted: 2015-11-13
First Post: 2013-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treating Wheezing in Children With Hypertonic Saline (TWICS)
Sponsor: Dr. Michael Flavin
Organization:

Study Overview

Official Title: Treating Wheezing in Children With Hypertonic Saline (TWICS)
Status: WITHDRAWN
Status Verified Date: 2014-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Funding declined. Study never initiated.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TWICS
Brief Summary: Hypothesis: substitution of nebulized 3% NaCl (HS) for the standard normal saline (NS) used in bronchodilator therapy for acute viral wheezing in all children under age 6 years will provide superior symptom relief leading to decreased admission rates from the Emergency Department.

The study will test the efficacy of frequent doses of inhaled bronchodilator co-administered with either 3% hypertonic saline (HS, study group) or 0.9% normal saline (NS, control group) in a prospective, double blind, randomized controlled, multi-centre clinical trial of children under age 6 years presenting to the ED with acute viral-associated wheezing.
Detailed Description: the brief summary captures the essence of the study

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
HSTWICS OTHER Queen's Department of Pediatrics View